Usp7 promotes medulloblastoma cell survival and metastasis by activating Shh pathway

Biochemical and Biophysical Research Communications

Volumn 484, Issue 2, 2017, Pages 429-434

  Zhan, Meixiao ^a,c   Sun, Xiaohan ^b   Liu, Jinxiao ^b   Li, Yan ^b   Li, Yong ^a,c   He, Xu ^c   Zhou, Zizhang ^b   Lu, Ligong ^a,c  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b SHANDONG AGRICULTURAL UNIVERSITY   (China)

^c JINAN UNIVERSITY   (China)

Author keywords

CRISPR Cas9; Medulloblastoma; P53; Shh; Usp7

Indexed keywords

DEUBIQUITINASE; DEUBIQUITINASE USP7; GLI PROTEIN; HHIP1 PROTEIN; PROTEIN; PROTEIN BCL 2; PROTEIN P53; PROTEIN PATCHED 1; SHH PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR GLI1; TRANSCRIPTION FACTOR GLI2; TRANSCRIPTION FACTOR GLI3; UNCLASSIFIED DRUG; SHH PROTEIN, HUMAN; SONIC HEDGEHOG PROTEIN; UBIQUITIN THIOLESTERASE; USP7 PROTEIN, HUMAN;

AMPLICON; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; FRAMESHIFT MUTATION; GENE EXPRESSION; MEDULLOBLASTOMA CELL LINE; METASTASIS; MIGRATION INHIBITION; MUTAGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SANGER SEQUENCING; WESTERN BLOTTING; CELL MOTION; GENE SILENCING; GENETICS; HUMAN; MEDULLOBLASTOMA; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

BASE SEQUENCE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; GENE KNOCKDOWN TECHNIQUES; HEDGEHOG PROTEINS; HUMANS; MEDULLOBLASTOMA; NEOPLASM METASTASIS; UBIQUITIN THIOLESTERASE;

EID: 85011094624     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2017.01.144     Document Type: Article

References (27)

1. [1] Hochstrasser, M., Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. Curr. Opin. Cell Biol. 7 (1995), 215–223.
2. [2] Hochstrasser, M., Ubiquitin and intracellular protein degradation. Curr. Opin. Cell Biol. 4 (1992), 1024–1031.
3. [3] Lam, Y.A., Xu, W., DeMartino, G.N., Cohen, R.E., Editing of ubiquitin conjugates by an isopeptidase in the 26S proteasome. Nature 385 (1997), 737–740.
4. [4] Wilkinson, K.D., Ubiquitination and deubiquitination: targeting of proteins for degradation by the proteasome. Semin. Cell Dev. Biol. 11 (2000), 141–148.
5. [5] Everett, R.D., Meredith, M., Orr, A., Cross, A., Kathoria, M., Parkinson, J., A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO J. 16 (1997), 1519–1530.
6. [6] Li, M., Chen, D., Shiloh, A., Luo, J., Nikolaev, A.Y., Qin, J., Gu, W., Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 416 (2002), 648–653.
7. [7] Song, M.S., Salmena, L., Carracedo, A., Egia, A., Lo-Coco, F., Teruya-Feldstein, J., Pandolfi, P.P., The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network. Nature 455 (2008), 813–817.
8. [8] Zhou, Z., Yao, X., Li, S., Xiong, Y., Dong, X., Zhao, Y., Jiang, J., Zhang, Q., Deubiquitination of Ci/Gli by Usp7/HAUSP regulates Hedgehog signaling. Dev. Cell 34 (2015), 58–72.
9. [9] Tavana, O., Li, D., Dai, C., Lopez, G., Banerjee, D., Kon, N., Chen, C., Califano, A., Yamashiro, D.J., Sun, H., Gu, W., HAUSP deubiquitinates and stabilizes N-Myc in neuroblastoma. Nat. Med. 22 (2016), 1180–1186.
10. [10] Masuya, D., Huang, C., Liu, D., Nakashima, T., Yokomise, H., Ueno, M., Nakashima, N., Sumitomo, S., The HAUSP gene plays an important role in non-small cell lung carcinogenesis through p53-dependent pathways. J. Pathol. 208 (2006), 724–732.
11. [11] Zhu, L., Liu, R., Zhang, W., Qian, S., Wang, J.H., MicroRNA-205 regulates ubiquitin specific peptidase 7 protein expression in hepatocellular carcinoma cells. Mol. Med. Rep. 12 (2015), 4652–4656.
12. [12] Rossi, A., Caracciolo, V., Russo, G., Reiss, K., Giordano, A., Medulloblastoma: from molecular pathology to therapy. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 14 (2008), 971–976.
13. [13] Guessous, F., Li, Y., Abounader, R., Signaling pathways in medulloblastoma. J. Cell. Physiol. 217 (2008), 577–583.
14. [14] Gibson, P., Tong, Y., Robinson, G., Thompson, M.C., Currle, D.S., Eden, C., Kranenburg, T.A., Hogg, T., Poppleton, H., Martin, J., Finkelstein, D., Pounds, S., Weiss, A., Patay, Z., Scoggins, M., Ogg, R., Pei, Y., Yang, Z.J., Brun, S., Lee, Y., Zindy, F., Lindsey, J.C., Taketo, M.M., Boop, F.A., Sanford, R.A., Gajjar, A., Clifford, S.C., Roussel, M.F., McKinnon, P.J., Gutmann, D.H., Ellison, D.W., Wechsler-Reya, R., Gilbertson, R.J., Subtypes of medulloblastoma have distinct developmental origins. Nature 468 (2010), 1095–1099.
15. [15] Zhou, Z., Xu, C., Chen, P., Liu, C., Pang, S., Yao, X., Zhang, Q., Stability of HIB-Cul3 E3 ligase adaptor HIB is regulated by Self-degradation and Availability of its substrates. Sci. Rep., 5, 2015, 12709.
16. [16] He, S., Wang, F., Yang, L., Guo, C., Wan, R., Ke, A., Xu, L., Hu, G., Xu, X., Shen, J., Wang, X., Expression of DNMT1 and DNMT3a are regulated by GLI1 in human pancreatic cancer. PLoS One, 6, 2011, e27684.
17. [17] Nicholson, B., Suresh Kumar, K.G., The multifaceted roles of USP7: new therapeutic opportunities. Cell Biochem. Biophys. 60 (2011), 61–68.
18. [18] Di Marcotullio, L., Ferretti, E., Greco, A., De Smaele, E., Po, A., Sico, M.A., Alimandi, M., Giannini, G., Maroder, M., Screpanti, I., Gulino, A., Numb is a suppressor of Hedgehog signalling and targets Gli1 for Itch-dependent ubiquitination. Nat. Cell Biol. 8 (2006), 1415–1423.
19. [19] Chauhan, D., Tian, Z., Nicholson, B., Kumar, K.G., Zhou, B., Carrasco, R., McDermott, J.L., Leach, C.A., Fulcinniti, M., Kodrasov, M.P., Weinstock, J., Kingsbury, W.D., Hideshima, T., Shah, P.K., Minvielle, S., Altun, M., Kessler, B.M., Orlowski, R., Richardson, P., Munshi, N., Anderson, K.C., A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance. Cancer Cell 22 (2012), 345–358.
20. [20] Fan, Y.H., Cheng, J., Vasudevan, S.A., Dou, J., Zhang, H., Patel, R.H., Ma, I.T., Rojas, Y., Zhao, Y., Yu, Y., Zhang, H., Shohet, J.M., Nuchtern, J.G., Kim, E.S., Yang, J., USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis. Cell Death Dis., 4, 2013, e867.
21. [21] Northcott, P.A., Jones, D.T., Kool, M., Robinson, G.W., Gilbertson, R.J., Cho, Y.J., Pomeroy, S.L., Korshunov, A., Lichter, P., Taylor, M.D., Pfister, S.M., Medulloblastomics: the end of the beginning. Nat. Rev. Cancer 12 (2012), 818–834.
22. [22] Louis, D.N., Ohgaki, H., Wiestler, O.D., Cavenee, W.K., Burger, P.C., Jouvet, A., Scheithauer, B.W., Kleihues, P., The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 114 (2007), 97–109.
23. [23] Samkari, A., White, J., Packer, R., SHH inhibitors for the treatment of medulloblastoma. Expert Rev. Neurother. 15 (2015), 763–770.
24. [24] Ruiz i Altaba, A., Palma, V., Dahmane, N., Hedgehog-Gli signalling and the growth of the brain. Nat. Rev. Neurosci. 3 (2002), 24–33.
25. [25] Heride, C., Rigden, D.J., Bertsoulaki, E., Cucchi, D., De Smaele, E., Clague, M.J., Urbe, S., The centrosomal deubiquitylase USP21 regulates Gli1 transcriptional activity and stability. J. Cell Sci. 129 (2016), 4001–4013.
26. [26] Li, S., Chen, Y., Shi, Q., Yue, T., Wang, B., Jiang, J., Hedgehog-regulated ubiquitination controls smoothened trafficking and cell surface expression in Drosophila. PLoS Biol., 10, 2012, e1001239.
27. [27] Yang, Z., Huo, S., Shan, Y., Liu, H., Xu, Y., Yao, K., Li, X., Zhang, X., STAT3 repressed USP7 expression is crucial for colon cancer development. FEBS Lett. 586 (2012), 3013–3017.